Management of high-risk biochemical recurrence in prostate cancer: A GCC Delphi consensus (BEAM Panel)
{{output}}
Background: High-risk biochemical recurrence (HR-BCR) of prostate cancer (PC) is a prostate-specific antigen (PSA)-only relapse state in which rapid PSA kinetics predict early metastatic progression. Variation in care pathways ac... ...
